Icosavax, Inc. (ICVX): Price and Financial Metrics

Icosavax, Inc. (ICVX): $15.31

0.14 (-0.91%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add ICVX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#230 of 358

in industry

ICVX Price/Volume Stats

Current price $15.31 52-week high $16.10
Prev. close $15.45 52-week low $4.75
Day low $15.28 Volume 9,315,200
Day high $15.44 Avg. volume 1,215,776
50-day MA $15.08 Dividend yield N/A
200-day MA $10.06 Market Cap 766.88M

ICVX Stock Price Chart Interactive Chart >


Icosavax, Inc. (ICVX) Company Bio


Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-A12, an respiratory syncytial virus (RSV) monovalent antigen candidate with RSV/human metapneumovirus (hMPV) bivalent target indication; IVX-121, a vaccine candidate with RSV target; IVX-241, a vaccine candidate with hMPV target; IVX-411, an original receptor binding domain (RBD) sequence antigen with SARS-CoV-2^ target indication; and IVX-421, a variant RBD antigen with SARS-CoV-2^ target indication. The company was incorporated in 2017 and is headquartered in Seattle, Washington.


ICVX Latest News Stream


Event/Time News Detail
Loading, please wait...

ICVX Latest Social Stream


Loading social stream, please wait...

View Full ICVX Social Stream

ICVX Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year 50.39%
3-year -40.22%
5-year N/A
YTD -2.86%
2023 98.49%
2022 -65.30%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!